| Gene symbol | WT1 | Synonyms | AWT1, GUD, NPHS4, WAGR, WIT-2, WT-1, WT33 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11p13 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | WT1 transcription factor | ||||
| GTO ID | GTC2705 |
| Trial ID | NCT04911621 |
| Disease | Brain Glioma |
| Altered gene | WT1 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | mRNA vaccine |
| Treatment | DC Vaccine |
| Co-treatment | temozolomide-based chemoradiation |
| Phase | Phase1|Phase2 |
| Recruitment status | Active, Not Recruiting |
| Title | Adjuvant Dendritic Cell Immunotherapy Complementing Conventional Therapy for Pediatric Patients With High-grade Glioma and Diffuse Intrinsic Pontine Glioma |
| Year | 2021 |
| Country | Belgium |
| Company sponsor | University Hospital, Antwerp |
| Other ID(s) | CCRG19-002 |
| Vector information | |||
|
|||
| Cohort1: temozolomide-based chemoradiation | |||||
|
|||||
| Cohort2: conventional next-line treatment | |||||
|
|||||